echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Over $3 billion!

    Over $3 billion!

    • Last Update: 2022-01-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On January 10, Bristol-Myers Squibb (BMS) and Century Therapeutics (“Century”) announced a research collaboration and license agreement to jointly develop and commercialize iPSC-derived allogeneic cell therapies planned for the treatment of Hematological malignancies and solid tumors


    Under the terms of the collaboration, Century will be responsible for developing candidate discovery and preclinical development activities


    Century mainly focuses on the development of allogeneic T cell therapy or NK cell therapy, its allogeneic T cell therapy by knockout

    β2M, CIITA and knock-in HLA-E for allogeneic therapy


    Original in English: https://investors.


    https://investors.
    centurytx.
    com/news-releases/news-release-details/century-therapeutics-and-bristol-myers-squibb-enter-strategic
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.